These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4003004)

  • 1. Current concepts on the activation of Hageman factor (factor XII).
    Saito H
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):170-6. PubMed ID: 4003004
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of expression of monocyte interleukin-1 by inhibitors of Hageman factor (factor XII).
    Ratnoff OD; Voytus JA; Toossi Z
    J Lab Clin Med; 1995 Feb; 125(2):247-50. PubMed ID: 7844472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hageman complement and factor.
    Kim Z
    Ann Allergy; 1977 Mar; 38(3):211-4. PubMed ID: 842908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].
    Damas J; Adam A
    Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait.
    Smink MM; Daniel TM; Ratnoff OD; Stavitsky AB
    J Lab Clin Med; 1967 May; 69(5):819-32. PubMed ID: 4960805
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 10. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
    Austen KF
    Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
    [No Abstract]   [Full Text] [Related]  

  • 11. The "Hageman" connection: interrelationships of blood coagulation, fibrinogenolysis, kinin generation, and complement activation.
    Murano G
    Przegl Lek; 1981; 38(10):709-13. PubMed ID: 7330256
    [No Abstract]   [Full Text] [Related]  

  • 12. Hageman factor.
    Finley PR
    Ann Clin Lab Sci (1971); 1972; 2(1):37-9. PubMed ID: 5081900
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of Hageman factor dependent pathways in human disease states.
    Colman RW; Wong PY
    Thromb Haemost; 1977 Dec; 38(4):751-75. PubMed ID: 341410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.